OPIANT Trademark

Trademark Overview


On Thursday, May 19, 2022, a trademark application was filed for OPIANT with the United States Patent and Trademark Office. The USPTO has given the OPIANT trademark a serial number of 97975168. The federal status of this trademark filing is REGISTERED as of Tuesday, December 6, 2022. This trademark is owned by Opiant Pharmaceuticals, Inc.. The OPIANT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services; pharmaceutical research services; development of pharmaceutical preparations and medicines for the treatment of neurological and psychiatric diseases and disorders relating to drug and chemical addictions, drug overdoses and eating disorders
opiant

General Information


Serial Number97975168
Word MarkOPIANT
Filing DateThursday, May 19, 2022
Status700 - REGISTERED
Status DateTuesday, December 6, 2022
Registration Number6919901
Registration DateTuesday, December 6, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 2, 2022

Trademark Statements


Goods and ServicesPharmaceutical drug development services; pharmaceutical research services; development of pharmaceutical preparations and medicines for the treatment of neurological and psychiatric diseases and disorders relating to drug and chemical addictions, drug overdoses and eating disorders

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, May 25, 2022
Primary Code042
First Use Anywhere DateTuesday, May 31, 2016
First Use In Commerce DateTuesday, May 31, 2016

Trademark Owner History


Party NameINDIVIOR INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressNORTH CHESTERFIELD, VA 23235

Party NameOpiant Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSanta Monica, CA 90401

Party NameOpiant Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSanta Monica, CA 90401

Party NameOpiant Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSanta Monica, CA 90401

Trademark Events


Event DateEvent Description
Monday, September 18, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 18, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 18, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 18, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, September 18, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 21, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, December 6, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 6, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, November 3, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, November 2, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, October 28, 2022STATEMENT OF USE PROCESSING COMPLETE
Monday, October 10, 2022USE AMENDMENT FILED
Friday, October 28, 2022DIVISIONAL PROCESSING COMPLETE
Monday, October 10, 2022DIVISIONAL REQUEST RECEIVED
Monday, October 24, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 10, 2022TEAS REQUEST TO DIVIDE RECEIVED
Monday, October 10, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, September 27, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 2, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 2, 2022PUBLISHED FOR OPPOSITION
Wednesday, July 13, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, June 24, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 24, 2022ASSIGNED TO EXAMINER
Wednesday, May 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 23, 2022NEW APPLICATION ENTERED